Among heart attack survivors, drug reduces chances of second heart attack or stroke

(University of Colorado Anschutz Medical Campus) In a clinical trial involving 18,924 patients from 57 countries who had suffered a recent heart attack or threatened heart attack, researchers at the University of Colorado Anschutz Medical Campus and fellow scientists around the world have found that the cholesterol-lowering drug alirocumab reduced the chance of having additional heart problems or stroke.

from EurekAlert! - Social and Behavioral Science https://ift.tt/2JLFYWp